Literature DB >> 20507868

Epidemiology and meningococcal serogroup distribution in the United States.

Jody H Hershey1, William Hitchcock.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20507868     DOI: 10.1177/0009922809347797

Source DB:  PubMed          Journal:  Clin Pediatr (Phila)        ISSN: 0009-9228            Impact factor:   1.168


× No keyword cloud information.
  5 in total

1.  Safety and immunogenicity of the tetravalent protein-conjugated meningococcal vaccine (MCV4) in recipients of related and unrelated allogeneic hematopoietic stem cell transplantation.

Authors:  Michelle B Mahler; Ying Taur; Raymond Jean; Nancy A Kernan; Susan E Prockop; Trudy N Small
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-04       Impact factor: 5.742

Review 2.  The changing epidemiology of meningococcal disease in North America 1945-2010.

Authors:  Carmen Baccarini; Andrew Ternouth; Heather Wieffer; Andrew Vyse
Journal:  Hum Vaccin Immunother       Date:  2012-10-29       Impact factor: 3.452

3.  Critical appraisal of a quadrivalent CRM(197) conjugate vaccine against meningococcal serogroups A, C W-135 and Y (Menveo) in the context of treatment and prevention of invasive disease.

Authors:  Michael Bröker; Brian Cooper; Lisa M Detora; Jeffrey J Stoddard
Journal:  Infect Drug Resist       Date:  2011-07-22       Impact factor: 4.003

4.  Symptomatic Vaginal Infection by Neisseria meningitidis Resulting in Meningitis with Septic Shock.

Authors:  Ryan Offman; Elissa Boggs; Adam Gwizdala
Journal:  Clin Pract Cases Emerg Med       Date:  2019-03-27

5.  Demographic Features of Invasive Meningococcal Disease in Taiwan, 1993 to 2020, and Genetic Characteristics of Neisseria meningitidis Isolates, 2003 to 2020.

Authors:  Chien-Shun Chiou; Ying-Shu Liao; Bo-Han Chen; Min-Chi Lu; Yu-Ping Hong; You-Wun Wang; Ru-Hsiou Teng
Journal:  Microbiol Spectr       Date:  2022-07-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.